Need help now? Free crisis lines and helplines, worldwide — chapter 02 →
0 results for

Damp, Mould & Indoor Air — What the Research Shows

Category 20 of 20 in chapter 17, The Research Behind It, of Notbroken's Free Metabolic & Mental Health Help Directory: 14 listings, each carefully picked (listed, not endorsed). All 280 listings in The Research Behind It · Open the full directory of 2299 listings.
14
Listings
20 / 20
Category
17 / 18
Chapter
Latest Edition Always download the most up-to-date version, free, at notbroken.io
Know someone who could benefit? Share this guide with them.
Free to use · No account needed
Navigation
Contents
17
The Research Behind It — Free Papers on Chronic Disease and What the Evidence Shows
THE EVIDENCE
THE EVIDENCE

The Research Behind It — Free Papers on Chronic Disease and What the Evidence Shows

Why would a support group, a walking club, a low-carb book or an online CBT course help — and what drives chronic illness in the first place? This chapter gathers the research behind each part of the directory, and the research on causes: metabolic therapies, the nutrients in food, plastics and pollution, stress and trauma, the microbiome, and damp and mould. That is 280 studies, reviews and clinical guidelines, every one free to read and download in full, permanently and without a login. Most are kept in PubMed Central, the US National Library of Medicine's public archive; the rest are open access at the publisher, or free guidance from the World Health Organization and NICE. Each entry says what was found, why it matters here — which listings it backs up, or what it explains about chronic disease — and how strong the evidence is: strong (systematic reviews and guidelines with consistent findings), moderate (smaller or lower-certainty reviews, single large trials and large cohort studies) or early (pilot, cross-sectional and laboratory studies — promising, not proof). Studies that follow people over time show links, not proof of cause, and the entries say so. Where a study was funded by a company, or its authors run a listed programme, the note says so; where a listed book or service was not itself tested, the entry says it backs the approach rather than the product. Research moves on, so read these as good reasons to try something, not guarantees — and talk to your own clinician before changing a treatment or a medicine. Every paper was checked at least twice: by the researcher who chose it and again, independently, against its abstract and full text (the first 186 a third time); its public record was checked for corrections, retractions and expressions of concern (none is retracted), every number was looked up in the full text, and every link was opened in a browser.

Damp, Mould & Indoor Air — What the Research Shows

WHO guidelines for indoor air quality: dampness and mould — WHO 2009

WHO guideline — expert review of epidemiological, clinical and toxicological evidence (WHO working group, 2007). Moderate evidence. Copenhagen: WHO Regional Office for Europe, 2009. ISBN 978 92 890 4168 3. Free from the World Health Organization. Note: Evidence reviewed to 2007 and mostly observational; WHO found consistent links but judged that causation was not yet established and could not identify the microbes responsible.
What It Found
WHO's expert review found sufficient evidence that people in damp or mouldy homes and public buildings are at higher risk of respiratory symptoms, respiratory infections and asthma flare-ups, with some evidence for allergic rhinitis and asthma; mould exposure also raises the risk of rare conditions such as hypersensitivity pneumonitis. As the risk could not be quantified, WHO sets no numeric limits; it advises preventing damp and mould and fixing them when they occur.
Why It Matters Here
Explains that damp and mould are linked with breathing problems, can be prevented, and should be fixed at the source (leaks, condensation, poor ventilation); most relevant to people with asthma or allergies, and to families in damp housing.
WHO guideline — expert review of epidemiological, clinical and toxicological evidence (WHO working group, 2007). Moderate evidence. Copenhagen: WHO Regional Office for Europe, 2009. ISBN 978 92 890 4168 3. Free from the World Health Organization. Note: Evidence reviewed to 2007 and mostly observational; WHO found consistent links but judged that causation was not yet established and could not identify the microbes responsible.

Respiratory and Allergic Health Effects of Dampness, Mold, and Dampness-Related Agents: A Review of the Epidemiologic Evidence — Mendell et al., Environ Health Perspect 2011

Review of epidemiological evidence — 103 studies published after the 2004 US Institute of Medicine review, plus that review's 45 studies (to late 2009). Moderate evidence. Environ Health Perspect 2011;119(6):748–756. DOI 10.1289/ehp.1002410. Free full text in PubMed Central (PMC3114807) — public domain. Note: Mostly observational studies to 2009, so for most outcomes it shows consistent links rather than proof that mould is the cause.
What It Found
Updating the US Institute of Medicine's 2004 review with 103 newer studies, the authors found damp or mould seen or smelt indoors consistently linked with new and worsening asthma, wheeze, cough, breathlessness, respiratory infections, bronchitis, allergic rhinitis and eczema, in allergic and non-allergic people. Evidence strongly suggested damp or mould causes asthma flare-ups in children. Evidence did not support measuring specific moulds or microbes to guide action.
Why It Matters Here
Explains which illnesses are linked with visible damp and mould, and why fixing the damp matters more than laboratory testing of a home; relevant to families with asthma, eczema or allergies and to anyone offered mould testing.
Review of epidemiological evidence — 103 studies published after the 2004 US Institute of Medicine review, plus that review's 45 studies (to late 2009). Moderate evidence. Environ Health Perspect 2011;119(6):748–756. DOI 10.1289/ehp.1002410. Free full text in PubMed Central (PMC3114807) — public domain. Note: Mostly observational studies to 2009, so for most outcomes it shows consistent links rather than proof that mould is the cause.

Indoor mould exposure, asthma and rhinitis: findings from systematic reviews and recent longitudinal studies — Caillaud et al., Eur Respir Rev 2018

Systematic review for France's health-safety agency ANSES — 61 publications from 2006–2017 (7 meta-analyses, 4 systematic reviews, longitudinal, incident case-control and panel studies). Moderate evidence. Eur Respir Rev 2018;27(148):170137. DOI 10.1183/16000617.0137-2017. Free full text in PubMed Central (PMC9489198) — open access, CC BY-NC 4.0. Note: A narrative synthesis of observational studies without pooled estimates; evidence in adults outside the workplace remains limited.
What It Found
Experts for France's health-safety agency (ANSES) reviewed 61 publications from 2006–2017, focusing on studies that followed people over time. In children, visible mould and mould odour were linked with developing asthma and with asthma attacks, which they judged sufficient evidence of a causal relationship. In adults the evidence was limited, apart from asthma linked with mouldy workplaces. Evidence of a link with allergic rhinitis was sufficient.
Why It Matters Here
Explains the evidence that mouldy homes can bring on and worsen childhood asthma; most relevant to parents of children with asthma or wheeze, and to adults whose breathing is worse in a damp workplace.
Systematic review for France's health-safety agency ANSES — 61 publications from 2006–2017 (7 meta-analyses, 4 systematic reviews, longitudinal, incident case-control and panel studies). Moderate evidence. Eur Respir Rev 2018;27(148):170137. DOI 10.1183/16000617.0137-2017. Free full text in PubMed Central (PMC9489198) — open access, CC BY-NC 4.0. Note: A narrative synthesis of observational studies without pooled estimates; evidence in adults outside the workplace remains limited.

Childhood asthma and mould in homes—A meta-analysis — Varga et al., Wien Klin Wochenschr 2025

Systematic review and meta-analysis — 32 observational studies of children (11 cohort, 21 case-control). Moderate evidence. Wien Klin Wochenschr 2025;137(3–4):79–88. DOI 10.1007/s00508-024-02396-4. Free full text in PubMed Central (PMC11794369) — open access, CC BY 4.0. Note: Observational studies: the stronger cohort studies found a smaller, less consistent effect, and case-control results may be inflated by parents' recall of mould.
What It Found
Pooling 11 cohort and 21 case-control studies of children, the authors found that living in a mouldy home was linked with a higher chance of later developing asthma: 53% higher odds in the case-control studies (OR 1.53, 95% CI 1.42–1.65) and 15% higher in the cohort studies (OR 1.15, 95% CI 1.01–1.31), with no sign of publication bias. Results of the cohort studies varied considerably.
Why It Matters Here
Explains that early-life exposure to a mouldy home may help bring on childhood asthma, not only trigger attacks; most relevant to parents of babies and young children living with damp or mould.
Systematic review and meta-analysis — 32 observational studies of children (11 cohort, 21 case-control). Moderate evidence. Wien Klin Wochenschr 2025;137(3–4):79–88. DOI 10.1007/s00508-024-02396-4. Free full text in PubMed Central (PMC11794369) — open access, CC BY 4.0. Note: Observational studies: the stronger cohort studies found a smaller, less consistent effect, and case-control results may be inflated by parents' recall of mould.

Association of residential dampness and mold with respiratory tract infections and bronchitis: a meta-analysis — Fisk et al., Environ Health 2010

Meta-analysis — 23 observational studies (mostly cross-sectional). Moderate evidence. Environ Health 2010;9:72. DOI 10.1186/1476-069X-9-72. Free full text in PubMed Central (PMC3000394) — open access, CC BY 2.0. Note: Mostly one-off surveys with self-reported damp, so other factors may explain part of the link; the authors say causation is not yet confirmed.
What It Found
Across 23 studies, damp or mould at home was linked with about 45% higher odds of bronchitis (OR 1.45, 95% CI 1.32–1.59) and of respiratory infections (OR 1.44, 1.31–1.59) in studies adjusted for age, sex, smoking and socioeconomic status, and 48% higher odds of respiratory infections in children (OR 1.48, 1.33–1.65). If the link is causal, damp and mould would account for an estimated 8–20% of these infections.
Why It Matters Here
Explains why children and adults in damp or mouldy homes may get more respiratory infections and bronchitis; relevant to families dealing with frequent coughs and colds.
Meta-analysis — 23 observational studies (mostly cross-sectional). Moderate evidence. Environ Health 2010;9:72. DOI 10.1186/1476-069X-9-72. Free full text in PubMed Central (PMC3000394) — open access, CC BY 2.0. Note: Mostly one-off surveys with self-reported damp, so other factors may explain part of the link; the authors say causation is not yet confirmed.

Damp mouldy housing and early childhood hospital admissions for acute respiratory infection: a case control study — Ingham et al., Thorax 2019

Case-control study — 188 children under 2 admitted with acute respiratory infection and 454 controls, Wellington, New Zealand (2011–2013). Early evidence. Thorax 2019;74(9):849–857. DOI 10.1136/thoraxjnl-2018-212979. Free full text in PubMed Central (PMC6824607) — open access, CC BY-NC 4.0. Note: Observational study in one city; the broader housing-quality score lost significance after adjustment, although the damp-mould score held.
What It Found
Independent building assessors, who did not know which children were cases, inspected the homes of 642 children under two in Wellington, New Zealand. Each one-point rise on an 8-item damp-mould index was linked with 15% higher odds of hospital admission for a respiratory infection (adjusted OR 1.15, 95% CI 1.02–1.30). The authors estimate that removing damp and mould could cut these admissions by 19%, about 1,700 fewer a year in New Zealand.
Why It Matters Here
Explains the link between damp, mouldy homes and respiratory infections serious enough to need hospital care in babies and toddlers; relevant to parents of young children and to renters seeking repairs.
Case-control study — 188 children under 2 admitted with acute respiratory infection and 454 controls, Wellington, New Zealand (2011–2013). Early evidence. Thorax 2019;74(9):849–857. DOI 10.1136/thoraxjnl-2018-212979. Free full text in PubMed Central (PMC6824607) — open access, CC BY-NC 4.0. Note: Observational study in one city; the broader housing-quality score lost significance after adjustment, although the damp-mould score held.

A State-of-the-Science Review of the Effect of Damp- and Mold-Affected Housing on Mental Health — Gatto et al., Environ Health Perspect 2024

State-of-the-science review — 19 observational studies, 2003–2023 (63% cross-sectional). Early evidence. Environ Health Perspect 2024;132(8):086001. DOI 10.1289/EHP14341. Free full text in PubMed Central (PMC11334706) — public domain. Note: Mostly one-off surveys the authors judged low quality; it shows a link, not cause, and the link may partly reflect other housing problems or run both ways.
What It Found
University of Melbourne researchers reviewed 19 studies from 2003–2023 on damp or mould at home and mental health. Most reported links with poorer mental health: depression, stress and anxiety in adults, postnatal depression in mothers, and emotional symptoms and difficulty regulating emotions in children. The authors judged the studies generally low in quality and call for better research.
Why It Matters Here
Explains that a damp, mouldy home may weigh on mental as well as physical health, through stress and worry and possibly biological effects; relevant to people whose low mood or anxiety is tied up with poor housing.
State-of-the-science review — 19 observational studies, 2003–2023 (63% cross-sectional). Early evidence. Environ Health Perspect 2024;132(8):086001. DOI 10.1289/EHP14341. Free full text in PubMed Central (PMC11334706) — public domain. Note: Mostly one-off surveys the authors judged low quality; it shows a link, not cause, and the link may partly reflect other housing problems or run both ways.

Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract symptoms, infections and asthma — Sauni et al., Cochrane Database Syst Rev 2015

Cochrane systematic review — 12 studies, 8,028 people (3 randomised trials, one a cluster trial of 4,407 people, and 9 controlled before-after studies). Moderate evidence. Cochrane Database Syst Rev 2015;(2):CD007897. DOI 10.1002/14651858.CD007897.pub3. Free full text in PubMed Central (PMC6769180). Note: Few, varied studies (only three randomised) with mostly self-reported symptoms; evidence ranged from moderate to very low quality, and searches ended in 2014.
What It Found
Twelve studies (8,028 people) tested repairing damp, mouldy homes, schools or an office. Pooling two trials in homes, repairs reduced wheeze in adults (OR 0.64, 95% CI 0.55–0.75) and rhinitis, counted as a respiratory infection (OR 0.57, 0.49–0.66), with moderate-quality evidence. In one trial in children with asthma, home repairs did not clearly reduce symptom days or emergency visits compared with information only. School repairs gave inconsistent results.
Why It Matters Here
Explains that fixing the cause of damp and removing mould may ease asthma symptoms and respiratory infections in adults; relevant to people with asthma, renters seeking repairs and anyone weighing whether remediation is worth it.
Cochrane systematic review — 12 studies, 8,028 people (3 randomised trials, one a cluster trial of 4,407 people, and 9 controlled before-after studies). Moderate evidence. Cochrane Database Syst Rev 2015;(2):CD007897. DOI 10.1002/14651858.CD007897.pub3. Free full text in PubMed Central (PMC6769180). Note: Few, varied studies (only three randomised) with mostly self-reported symptoms; evidence ranged from moderate to very low quality, and searches ended in 2014.

Effect of insulating existing houses on health inequality: cluster randomised study in the community — Howden-Chapman et al., BMJ 2007

Cluster randomised trial — 1,350 households, 4,407 people in seven low-income New Zealand communities. Moderate evidence. BMJ 2007;334(7591):460. DOI 10.1136/bmj.39070.573032.80. Free full text in PubMed Central (PMC1808149). Note: Health outcomes were self-reported by occupants who knew their home had been insulated, and the fall in hospital admissions was not significant.
What It Found
Insulating 1,350 low-income New Zealand homes made bedrooms slightly warmer (0.5 °C) and drier (relative humidity 2.3% lower) in winter while using less energy. People in insulated homes were less likely to report fair or poor health (OR 0.50, 95% CI 0.38–0.68), wheezing (OR 0.57, 0.47–0.70), children's days off school (OR 0.49, 0.31–0.80) and GP visits (OR 0.73, 0.62–0.87). The fall in hospital admissions for breathing problems was not statistically significant.
Why It Matters Here
Explains that insulating homes, making them warmer and drier, improved self-reported health and breathing in a randomised trial; relevant to renters, families and people with asthma in cold, damp housing.
Cluster randomised trial — 1,350 households, 4,407 people in seven low-income New Zealand communities. Moderate evidence. BMJ 2007;334(7591):460. DOI 10.1136/bmj.39070.573032.80. Free full text in PubMed Central (PMC1808149). Note: Health outcomes were self-reported by occupants who knew their home had been insulated, and the fall in hospital admissions was not significant.

Indoor air quality at home — NICE 2020

National guideline (England) — evidence reviews and committee recommendations, developed with Public Health England. Moderate evidence. NICE guideline NG149, published 8 January 2020. Free to read on the NICE website. Note: Written for England's housing and legal system; the committee found limited evidence for some links and relied partly on its own judgement.
What It Found
NICE recommends advising people how to cut damp and condensation (background ventilation, extractor fans, avoiding drying clothes indoors where possible, fixing leaks), to ventilate when cooking, especially with gas, to choose low-VOC and low-formaldehyde products, and not to smoke indoors. Health professionals should explain that damp, mould, nitrogen dioxide and other pollutants can worsen asthma, and ask about housing when cough or wheeze keeps returning.
Why It Matters Here
Explains practical steps to keep the air at home healthy and when to ask a landlord or council for help; most relevant to people with asthma, COPD or heart disease, pregnant women and families with young children.
National guideline (England) — evidence reviews and committee recommendations, developed with Public Health England. Moderate evidence. NICE guideline NG149, published 8 January 2020. Free to read on the NICE website. Note: Written for England's housing and legal system; the committee found limited evidence for some links and relied partly on its own judgement.

Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline — Raghu et al., Am J Respir Crit Care Med 2020

International clinical practice guideline (American Thoracic Society, Japanese Respiratory Society, Asociación Latinoamericana del Tórax) — six systematic reviews, GRADE recommendations. Moderate evidence. Am J Respir Crit Care Med 2020;202(3):e36–e69. DOI 10.1164/rccm.202005-2032ST. Free full text in PubMed Central (PMC7397797). Note: About diagnosis rather than prevention; it rests on limited direct evidence, and the trigger is not found in up to 60% of patients.
What It Found
Hypersensitivity pneumonitis is an immune-driven lung disease, sometimes with scarring, that develops in susceptible people exposed to an inhaled trigger. The guideline lists flooded or contaminated houses, humidifiers and home ventilation or cooling systems among sources of moulds and microbes that cause it, alongside birds and some chemicals. People with the non-scarring form who avoid the trigger may stabilise or recover fully; the scarring form has worse survival.
Why It Matters Here
Explains a rare but serious lung disease that household mould can cause, and why finding and removing the source matters; relevant to anyone with persistent, unexplained breathlessness or cough linked to a damp home or humidifier.
International clinical practice guideline (American Thoracic Society, Japanese Respiratory Society, Asociación Latinoamericana del Tórax) — six systematic reviews, GRADE recommendations. Moderate evidence. Am J Respir Crit Care Med 2020;202(3):e36–e69. DOI 10.1164/rccm.202005-2032ST. Free full text in PubMed Central (PMC7397797). Note: About diagnosis rather than prevention; it rests on limited direct evidence, and the trigger is not found in up to 60% of patients.

AWMF mold guideline “Medical clinical diagnostics for indoor mold exposure” – Update 2023 AWMF Register No. 161/001 — Hurraß et al., Allergol Select 2024

Consensus clinical guideline (AWMF S2k) of German-speaking medical societies — literature review with formal consensus (>95% agreement on key messages). Moderate evidence. Allergol Select 2024;8:90–198. DOI 10.5414/ALX02444E. Free full text in PubMed Central (PMC11097193) — open access, CC BY 2.5. Note: A consensus guideline rather than a formal systematic review; 'insufficient evidence' means a link is unproven, not disproven.
What It Found
German-speaking medical societies graded the evidence on indoor mould and disease: sufficient for links with allergic rhinitis, allergic asthma, hypersensitivity pneumonitis, respiratory infections, bronchitis and fungal infections in vulnerable people, but inadequate for chronic fatigue syndrome, autoimmune disease, multiple chemical sensitivity, neurotoxic effects, cancer or 'mycotoxicosis'. They advise against urine or blood mycotoxin tests.
Why It Matters Here
Explains what is and is not established about mould and illness: context for readers of the environmental-illness educator ISEAI (chapter 16) and for anyone offered a 'mould illness' diagnosis or mycotoxin test, including by some functional-medicine practitioners (chapter 01).
Consensus clinical guideline (AWMF S2k) of German-speaking medical societies — literature review with formal consensus (>95% agreement on key messages). Moderate evidence. Allergol Select 2024;8:90–198. DOI 10.5414/ALX02444E. Free full text in PubMed Central (PMC11097193) — open access, CC BY 2.5. Note: A consensus guideline rather than a formal systematic review; 'insufficient evidence' means a link is unproven, not disproven.

Exposure to formaldehyde and asthma outcomes: A systematic review, meta-analysis, and economic assessment — Lam et al., PLoS One 2021

Systematic review (Navigation Guide method, PROSPERO-registered) and meta-analysis — 90 human studies assessed in detail (51% cross-sectional). Moderate evidence. PLoS One 2021;16(3):e0248258. DOI 10.1371/journal.pone.0248258. Free full text in PubMed Central (PMC8011796) — public domain. Note: About half the studies were one-off surveys and exposure measures varied; a broader 2015 review of household VOCs found that evidence poor and inconsistent.
What It Found
Formaldehyde is given off by pressed-wood products such as particleboard, foam insulation and some household products. Reviewing 90 studies and pooling those in children, the authors linked each 10 µg/m³ rise with 20% higher odds of an asthma diagnosis (OR 1.20, 95% CI 1.02–1.41); the link with worse symptoms was smaller and not significant (OR 1.08, 0.92–1.28). They rated the evidence moderate quality and 'sufficient' for asthma in children and adults.
Why It Matters Here
Explains why choosing low-formaldehyde furniture, flooring and building materials may matter for people with asthma, especially in new homes or after renovation.
Systematic review (Navigation Guide method, PROSPERO-registered) and meta-analysis — 90 human studies assessed in detail (51% cross-sectional). Moderate evidence. PLoS One 2021;16(3):e0248258. DOI 10.1371/journal.pone.0248258. Free full text in PubMed Central (PMC8011796) — public domain. Note: About half the studies were one-off surveys and exposure measures varied; a broader 2015 review of household VOCs found that evidence poor and inconsistent.

Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies — Darby et al., BMJ 2005

Pooled analysis of individual data — 13 case-control studies in nine European countries, 7,148 people with lung cancer and 14,208 controls. Moderate evidence. BMJ 2005;330(7485):223. DOI 10.1136/bmj.38308.477650.63. Free full text in PubMed Central (PMC546066). Note: Observational (case-control) data from Europe; radon levels vary widely between regions, and most of the absolute risk falls on smokers.
What It Found
Radon is a natural radioactive gas that can build up indoors from the ground. Pooling 13 European studies, lung-cancer risk rose 16% (95% CI 5–31%) for every 100 Bq/m³ of long-term home radon, in a straight line with no sign of a safe threshold. By age 75, estimated risk at 0, 100 and 400 Bq/m³ was about 0.4%, 0.5% and 0.7% for lifelong non-smokers but about 10%, 12% and 16% for smokers. Radon was estimated to cause about 2% of cancer deaths in Europe.
Why It Matters Here
Explains a common, invisible indoor cause of lung cancer and why the risk is far greater for smokers; relevant to people in high-radon areas deciding whether to test their home.
Pooled analysis of individual data — 13 case-control studies in nine European countries, 7,148 people with lung cancer and 14,208 controls. Moderate evidence. BMJ 2005;330(7485):223. DOI 10.1136/bmj.38308.477650.63. Free full text in PubMed Central (PMC546066). Note: Observational (case-control) data from Europe; radon levels vary widely between regions, and most of the absolute risk falls on smokers.
Important Disclaimer
This directory is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making changes to your medication regimen or starting any new therapy.

This document does not guarantee the legitimacy, quality, or suitability of any business, organization, or practitioner listed within. The inclusion of any listing does not constitute an endorsement, recommendation, or verification of credentials. All organizations listed are independent entities over which the creators of this directory have no control or oversight.

This directory is intended to be used as a starting point and reference for the reader to conduct their own research, exercise their own judgment, and apply their own discretion before engaging with any listed organization or professional. Readers are strongly encouraged to independently verify credentials, read reviews, check licensing, and confirm current pricing and availability directly with each organization before committing to any services.

Costs, availability, contact details, and services may change at any time without notice. Information was accurate to the best of our knowledge at the time of publication.

About Notbroken.io: this directory and the accompanying Breathe, Calm, Sleep, Move, Eat, Track and Build tools were created by Nathan Leary, who runs and updates them. How each tool works, its safety notes, the privacy policy and terms of use are at notbroken.io/about, notbroken.io/privacy and notbroken.io/terms. The tools are general wellness aids, not medical devices, and Track is a personal journal that never gives medication advice.

If you are in crisis: Please contact your local emergency services immediately, or reach out to one of the following helplines:

International: Chapter 02 of this directory lists free helplines by situation and country; elsewhere use Find A Helpline — findahelpline.com
United States: 988 Suicide & Crisis Lifeline (call or text 988) • Crisis Text Line (text HOME to 741741)
United Kingdom: Samaritans — 116 123 (free, 24/7)
Canada: Talk Suicide Canada — 988 (call or text, 24/7)
Australia: Lifeline — 13 11 14 (24/7) • Beyond Blue — 1300 22 4636
New Zealand: Need to Talk? — 1737 (free, 24/7)
Europe: European Emergency Number — 112
India: iCall — 9152987821 • Vandrevala Foundation — 1860 2662 345
Singapore: Samaritans of Singapore — 1-767 (24/7)
Japan: TELL Lifeline — 03-5774-0992

No matches found

Nothing matched . Try broadening your search — remove a filter, use a single keyword, describe what you need in a sentence, or browse by a condition, a place, or a type of support.

Suggest a resource